Events

OSCARS Second open call for Open Science projects online launch event

When
NOV ’24
Fri
15

11:00 - 12:30

This was 2 years ago

Location

virtual

Programmes
  • Research Infrastructures

The OSCARS project (Open Science Clusters’ Action for Research and Society) organises an online launch event of the OSCARS Second open call for Open Science Projects. This launch event will provide information on the second OSCARS open call for Open Science and gives the opportunity to ask any question related to the call. The launch event is open to researchers from all scientific disciplines, data scientists and members of research infrastructures. The agenda and registration form for the launch event.

During the OSCARS project two open calls will be launched

To support the research communities to take up open science and foster the involvement of scientists in the European Open Science Cloud (EOSC), OSCARS will launch two open calls (in total worth about 16 million Euro) to select third-parties for the development of new, innovative Open Science projects or services, that together will drive the uptake of FAIR-data-intensive research throughout the European Research Area (ERA). Projects can be proposed in the field of any of the Science Clusters by any researcher, or group of researchers, through a cascading grant mechanism. The first open call closed on 15 May 2024 (overview of funded projects), the second call will open on 15 November 2024 and close on 15 January 2025.

What is the OSCARS project about?

OSCARS brings together world-class European Research Infrastructures (RIs) in the ESFRI roadmap and beyond to foster the uptake of Open Science in Europe. Such RIs are part of the five Science Clusters (Humanities and Social Sciences (SSHOC), Life Sciences (LIFE SCIENCE RI), Environmental Sciences (ENVRI), Photon and Neutron Science (PANOSC), Astronomy, Nuclear and Particle Physics (ESCAPE)), which have strived to make open data easily accessible to the users and the public, by providing FAIR data management policies and practices for enabling Open Science. Today, the Science Clusters are an integral part of the EOSC initiative and, through OSCARS, will further contribute to its development and implementation process.

 

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Event calendar

  • Climate, Energy, Mobility

Horizon Europe Cluster 5 info day + GREENET Brokerage event

NOV
Thu
19

This hybrid information day is organised by the European Commission and looks at Horizon Europe Cluster 5 funding opportunities in climate, energy and mobility under the 2027 call topics. Onsite participants can ask questions directly or through Slido, and online participants can also use the Q&A tool. Questions are expected to be accepted...

Read more
  • EIC

EIC 2027 online information day

NOV
Thu
19

An overview of the upcoming EIC funding opportunities and new features introduced in 2027. Speakers from the European Innovation Council and SMEs Executive Agency (EISMEA) and the Directorate-General for Research and Innovation (DG RTD) of the European Commission will present an overview of the main EIC funding schemes:  EIC Pathfinder:...

Read more
  • Missions

Fifth Forum for the EU Mission on Adaptation to Climate Change

NOV
Mon
23
NOV
Tue
24

As climate impacts intensify across Europe, this Forum will spotlight practical and replicable adaptation solutions that are making a difference on the ground. Participants will explore innovative tools being developed through Mission Projects to boost climate resilience, collaborate to co-design solutions tailored to their communities, and...

Read more

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.